Stock listing

TPEx:6785 Alar Pharmaceuticals Inc (昱展新藥) 股價

Follow Alar Pharmaceuticals Inc into a list and get an email when it puts out news.

Share price · TPEX:6785

$59.70 TWD -12.30 (-17.1%)

Close on Nov 20, 2026

Past year -74.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$59.70 – $65.20 TWDNov 20, 2026
Volume
198,624 sharesNov 20, 2026
Market cap
$3.99B TWDAt the close on Nov 20, 2026 · price × 66.80M shares outstanding
52-week range
$59.70 – $317.00 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$5.10M TWDMedian day 44,024 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Alar Pharmaceuticals Inc logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6785 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$59.70-12.30-17.1%$65.20$65.20$59.70198,624
$72.00-3.90-5.1%$75.00$75.00$72.0038,853
$75.90-1.20-1.6%$76.00$76.60$73.8057,465
$77.10-3.60-4.5%$80.30$81.60$77.1029,797
$80.70-0.20-0.2%$80.10$84.00$80.0024,232
$80.90+0.80+1.0%$80.10$81.00$77.7049,137
$80.10+3.60+4.7%$76.60$82.70$76.6061,336
$76.500.000.0%$77.00$77.00$75.1026,129
$76.50+2.70+3.7%$73.80$78.50$73.8045,077
$73.80-5.10-6.5%$71.10$77.00$71.10195,238
$78.90-4.00-4.8%$84.00$86.00$78.9071,756
$82.90+0.90+1.1%$82.40$85.50$80.2065,943
$82.00-4.50-5.2%$85.00$85.30$82.0072,794
$86.50+2.50+3.0%$84.10$86.50$84.1026,851
$84.00-1.00-1.2%$85.00$85.00$82.0025,645
$85.00-0.80-0.9%$84.20$87.50$84.0043,592
$85.80+0.30+0.4%$85.60$85.80$85.009,585
$85.50-1.40-1.6%$84.50$85.50$84.0012,435
$86.900.000.0%$86.90$86.90$86.900
$86.90-1.60-1.8%$88.20$88.30$86.3042,535
$88.50+2.30+2.7%$86.20$93.00$86.2084,473
$86.20-0.20-0.2%$86.40$86.40$86.0026,056
$86.40+0.70+0.8%$85.30$86.50$83.9026,987
$85.70+2.60+3.1%$83.10$86.80$83.1048,004
$83.10-1.60-1.9%$85.10$85.10$81.1069,000
$84.70-0.30-0.4%$84.20$85.30$84.2024,000
$85.00-1.20-1.4%$86.50$86.60$84.2072,000
$86.20-1.90-2.2%$88.10$88.20$86.0078,000
$88.10-2.70-3.0%$90.30$90.50$88.1077,001
$90.80-2.30-2.5%$92.10$92.20$90.10136,000
$93.10-1.30-1.4%$94.10$94.10$92.8044,026
$94.40-0.30-0.3%$94.70$94.80$94.0043,000
$94.70-0.60-0.6%$95.10$95.40$94.2033,012
$95.30+0.20+0.2%$95.30$96.00$95.0031,130
$95.10-1.10-1.1%$96.30$97.70$94.8066,030
$96.20-2.60-2.6%$97.30$97.40$96.2029,000
$98.80-0.10-0.1%$100.00$100.00$97.0044,021
$98.90+2.70+2.8%$96.60$99.20$96.2021,000
$96.20-3.30-3.3%$101.00$101.00$96.2082,000
$99.50+0.50+0.5%$99.80$100.00$98.0046,000
$99.00-5.00-4.8%$104.50$108.00$99.00226,050
$104.00+9.40+9.9%$95.00$104.00$94.10167,001
$94.60+0.60+0.6%$95.00$95.40$94.2016,000
$94.00+0.70+0.8%$91.30$94.50$91.3027,000
$93.30-0.70-0.7%$95.40$95.60$93.2015,040
$94.00-1.60-1.7%$96.70$96.70$93.1031,000
$95.60+1.00+1.1%$97.30$97.40$94.0037,000
$94.60+1.60+1.7%$94.00$96.00$92.4055,000
$93.00-1.00-1.1%$93.30$93.30$92.0052,000
$94.00+2.10+2.3%$92.00$94.10$91.1044,020
$91.90+1.20+1.3%$92.20$92.30$90.7027,010
$90.70-0.50-0.5%$91.20$92.70$90.6035,002
$91.20-1.00-1.1%$92.10$93.00$90.7045,000
$92.20-2.50-2.6%$94.10$94.60$92.2088,010
$94.70-0.60-0.6%$94.10$95.30$93.0063,000
$95.30-2.80-2.9%$97.20$97.20$95.2043,000
$98.10-1.20-1.2%$97.30$98.40$97.0030,000
$99.30+3.60+3.8%$95.80$99.80$95.7050,000
$95.70-3.10-3.1%$96.70$97.30$95.2071,023
$98.80-1.20-1.2%$98.20$98.80$97.0018,000
$100.00+0.80+0.8%$101.00$105.50$98.50178,000
$99.20+0.90+0.9%$98.10$100.50$97.0071,000
Ticker
TPEx:6785
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

Latest news

All Alar Pharmaceuticals Inc news

Alar Pharmaceuticals Inc on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 2 in all · newest Apr 6, 2026 · oldest 2026

Valuation

EV/sales 568× against a median of 2.1×: the highest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$1.70B TWD
P/E
Loss
EV/sales
568×
EV/EBITDA
Negative EBITDA
Price/book
1.7×
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Alar Pharmaceuticals Inc · TPEX:6785US$121.0MUS$51.66Mn/a568×n/a1.7×n/a0.0×n/a
PolyPid Ltd. · NASDAQ:PYPDUS$124.3MUS$119.3Mn/an/an/a23.1×n/a0.3×0.93
Compass Therapeutics, Inc. · NASDAQ:CMPXUS$123.9M−US$29.89Mn/an/an/a0.9×n/a0.1×1.22
Humacyte, Inc. · NASDAQ:HUMAUS$123.7MUS$96.01Mn/a40.1×n/a6.8×n/a2.0×2.56
Biomm SA · BMFBOVESPA:BIOM3US$122.6MUS$136.5M18.4×2.1×12.3×2.2×10.3%0.3×n/a
Invivyd, Inc. · NASDAQ:IVVDUS$122.0MUS$3.86Mn/a0.1×n/a0.8×−214.8%0.1×2.06
Satellos Bioscience Inc · TSX:MSCLUS$121.9MUS$69.23Mn/an/an/a2.5×n/a0.0×0.49
CANbridge Pharmaceuticals Inc. · HKEX:1228US$120.4MUS$111.5Mn/a13.3×n/an/a−146.4%n/an/a
Atrium Therapeutics, Inc. · NASDAQ:RNAUS$118.4M−US$113.0Mn/a−2.9×n/a0.6×−229.7%0.0×0.76
Adagene, Inc. · NASDAQ:ADAGUS$118.2M−US$3.65Mn/a−0.5×n/a1.1×−229.6%0.1×1.43
STCube, Inc. · KRX:052020US$117.7MUS$71.99Mn/a13.6×n/a2.6×−338.7%0.0×n/a
Median of the othersUS$122.0MUS$70.61M18.4×2.1×12.3×2.2×−222.2%0.1×1.22

Team and board

Officers

OfficerRole
Yung-Shun WenCEO
Vivian KangDirector of Finance

Board

DirectorRole
Charles LinChairman
Chen-Yu FangDirector
Shoei-Sheng LeeIndependent Director
Shu-Chin LiangIndependent Director
Su Fnag YangIndependent Director
Yung-Shun WenCEO

Events

QuarterResultsShare move
Q3 2024Nov 6, 2024 · After close+0.3%
Q2 2024Aug 7, 2024 · After close+0.3%

Open Events

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue2.75M5.82M469.3M800.0K0600.0K
Cost of revenue613.0K2.03M0
Gross profit2.14M3.79M469.3M800.0K600.0K
Research and development156.5M57.3M56.7M34.2M81.9M160.3M
Selling, general and administrative13.4M14.4M27.0M13.1M11.4M11.0M
Operating income-167.8M-67.9M391.2M-32.5M-64.2M-142.8M
Depreciation and amortization4.87M3.88M3.35M3.21M3.36M2.84M
EBITDA-162.9M-64.1M394.5M-29.3M-60.9M-139.9M
Interest expense81.0K27.0K63.0K22.0K21.0K33.0K
Income before tax-79.0M37.0M391.1M-32.5M-64.2M-142.8M
Income tax8.49M-12.7M
Net income-79.7M18.2M382.6M-19.9M-64.2M-142.8M
Earnings per share, basic-1.190.276.71-0.35-1.13-2.86

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents1.79B1.41B739.5M455.4M519.1M561.0M
Short-term investments502.9M1.03B156.5M30.9M22.7M128.5M
Receivables0840.0K0
Current assets2.35B2.44B903.0M497.6M528.7M591.4M128.5M
Total assets2.49B2.56B973.2M522.6M539.9M604.0M
Accounts payable145.0K
Current liabilities74.5M55.1M74.8M5.37M4.46M4.13M145.0K
Total debt1.41M2.69M949.0K1.52M
Total liabilities84.3M64.3M76.1M8.10M5.54M5.37M145.0K
Shareholders' equity2.40B2.49B897.1M514.5M534.4M598.6M
Shares outstanding66.8M66.8M57.1M57.0M57.0M49.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-171.0M-75.3M403.6M-32.9M-63.5M-141.9M
Capital spending-2.87M-1.23M-6.34M-1.14M-1.58M-385.0K
Free cash flow-173.9M-76.5M397.2M-34.1M-65.0M-142.3M
Cash from financing-1.28M-929.0K-932.0K549.1M
Dividends paid-16.7M-100.2M
Change in cash387.7M666.4M284.1M-63.7M-41.9M511.5M

Open Financials

Cap table

Built by 6ix from Alar Pharmaceuticals Inc’s releases

Common shares
66,800,000
Fully diluted
66,800,000

Fully diluted

LineShares
Common shares66,800,000

Share count over time

CountShares
Nov 22, 202666,800,000

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
林東和7.05M10.6%Oct 31, 2026
劉淑華6.81M10.2%Oct 31, 2026
薩摩亞商grand Spirit Investm1.2M1.8%Oct 31, 2026
文永順220K0.33%Oct 31, 2026
梁芮瑋32,0000.05%Oct 31, 2026
康宇寧30,0000.04%Oct 31, 2026
蘇美琍00.00%Oct 31, 2026
李水盛00.00%Oct 31, 2026
方承猷00.00%Oct 31, 2026
梁淑琴00.00%Oct 31, 2026
All 12 holders
HolderSharesOf the companyAs of
林東和Nov 22, 2026
劉淑華Nov 22, 2026

Funds

HolderSharesValueAs of
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF25,767US$94,231Jun 30, 2026
Emerging Markets Social Core Equity Portfolio7,000US$20,399Jul 31, 2026
Emerging Markets ex China Core Equity Portfolio4,000US$11,657Jul 31, 2026
The Emerging Markets Small Cap Series3,000US$8,742Jul 31, 2026
World ex U.S. Core Equity Portfolio3,000US$8,742Jul 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles LinChairman · Since at least Apr 6, 2026
Chen-Yu FangDirector · Since at least Nov 5, 2026
Shoei-Sheng LeeIndependent Director · Since at least Nov 5, 2026
Shu-Chin LiangIndependent Director · Since at least Nov 5, 2026
Su Fnag YangIndependent Director · Since at least Nov 5, 2026
Vivian KangDirector of Finance · Since at least Nov 5, 2026
Yung-Shun WenCEO · Since at least Apr 6, 2026

Open People

Log in to ask 6ix AI your own questions about Alar Pharmaceuticals Inc.